ROS-PIASγ cross talk channelizes ATM signaling from resistance to apoptosis during chemosensitization of resistant tumors

被引:18
作者
Mohanty, S. [1 ]
Saha, S. [1 ]
Hossain, D. Md S. [1 ]
Adhikary, A. [1 ]
Mukherjee, S. [1 ]
Manna, A. [1 ]
Chakraborty, S. [1 ]
Mazumdar, M. [1 ]
Ray, P. [1 ]
Das, K. [1 ]
Chakraborty, J. [1 ]
Sa, G. [1 ]
Das, T. [1 ]
机构
[1] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
apoptosis; drug resistance; ROS; NF kappa B; IKK gamma; PIAS gamma; NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; NECROSIS-FACTOR-ALPHA; T-CELL APOPTOSIS; DNA-DAMAGE; OXIDATIVE STRESS; ATAXIA-TELANGIECTASIA; GLIOBLASTOMA CELLS; GENE-EXPRESSION; CANCER;
D O I
10.1038/cddis.2013.534
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
With the existing knowledge of ATM's role in therapeutic resistance, the present study aimed at identifying the molecular mechanisms that influence ATM to oscillate between chemoresistance and chemosensitivity. We observed that the redox status of tumors functions as a major determinant of ATM-dependent 'resistance-to-apoptosis' molecular switch. At a low reactive oxygen species (ROS) condition during genotoxic insult, the ATM/sumoylated-IKK gamma interaction induced NF kappa B activation that resisted JNK-mediated apoptosis, whereas increasing cellular ROS restored ATM/JNK apoptotic signaling. A search for the upstream missing link revealed that high ROS induces oxidation and ubiquitin-mediated degradation of PIASc, thereby disrupting PIAS gamma-IKK gamma cross talk, a pre-requisite for IKK gamma sumoylation and subsequent NF kappa B activation. Interruption in the PIAS gamma-mediated resistance pathway channels ATM signaling toward ATM/JNK pro-death circuitry. These in vitro results also translated to sensitive and resistant tumor allograft mouse models in which low ROS-induced resistance was over-ruled in PIAS gamma knockout tumors, while its overexpression inhibited high ROS-dependent apoptotic cues. Cumulatively, our findings identified an unappreciated yet critical combinatorial function of cellular ROS and PIAS gamma in regulating ATM-mediated chemosensitization of resistant tumors. Thus, therapeutic strategies employing ROS upregulation to inhibit PIASc during genotoxic therapy may, in future, help to eliminate the problems of NFjB-mediated tumor drug resistance.
引用
收藏
页码:e1021 / e1021
页数:12
相关论文
共 53 条
[1]   Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk [J].
Adhikary, Arghya ;
Mohanty, Suchismita ;
Lahiry, Lakshmishri ;
Hossain, Dewan Md Sakib ;
Chakraborty, Samik ;
Das, Tanya .
FEBS LETTERS, 2010, 584 (01) :7-14
[2]   The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFκb [J].
Albor, Amador ;
El-Hizawi, Sally ;
Horn, Elizabeth J. ;
Laederich, Melanie ;
Frosk, Patrick ;
Wrogemann, Klaus ;
Kulesz-Martin, Molly .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) :25850-25866
[3]   ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS [J].
Alexander, Angela ;
Cai, Sheng-Li ;
Kim, Jinhee ;
Nanez, Adrian ;
Sahin, Mustafa ;
MacLean, Kirsteen H. ;
Inoki, Ken ;
Guan, Kun-Liang ;
Shen, Jianjun ;
Person, Maria D. ;
Kusewitt, Donna ;
Mills, Gordon B. ;
Kastan, Michael B. ;
Walker, Cheryl Lyn .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) :4153-4158
[4]   NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation-Induced Apoptosis [J].
Berger, Rebecca ;
Jennewein, Claudia ;
Marschall, Viola ;
Karl, Sabine ;
Cristofanon, Silvia ;
Wagner, Liane ;
Vellanki, Sri HariKrishna ;
Hehlgans, Stephanie ;
Roedel, Franz ;
Debatin, Klaus-Michael ;
Ludolph, Albert C. ;
Fulda, Simone .
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (10) :1867-1875
[5]   Tumor-induced oxidative stress perturbs nuclear factorr-κB activity-augmenting tumor necrosis factor-α-mediated T-cell death:: Protection by curcumin [J].
Bhattacharyya, Sankar ;
Mandal, Debaprasad ;
Sen, Gouri Sankar ;
Pal, Suman ;
Banerjee, Shuvomoy ;
Lahiry, Lakshmishri ;
Finke, James H. ;
Tannenbaum, Charles S. ;
Das, Tanya ;
Sa, Gaurisankar .
CANCER RESEARCH, 2007, 67 (01) :362-370
[6]   Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes [J].
Bossis, G ;
Melchior, F .
MOLECULAR CELL, 2006, 21 (03) :349-357
[7]   Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells [J].
Chakraborty, Juni ;
Banerjee, Shuvomoy ;
Ray, Pallab ;
Hossain, Dewan Md Sakib ;
Bhattacharyya, Sankar ;
Adhikary, Arghya ;
Chattopadhyay, Sreya ;
Das, Tanya ;
Sa, Gaurisankar .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (43) :33104-33112
[8]   Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanism [J].
Chiou, Jeng-Fong ;
Tai, Cheng-Jeng ;
Wang, Yu-Huei ;
Liu, Tsan-Zon ;
Jen, Yee-Min ;
Shiau, Chia-Yang .
CANCER BIOLOGY & THERAPY, 2009, 8 (20) :1904-1913
[9]   Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro [J].
Choudhuri, SK ;
Chatterjee, A .
ANTI-CANCER DRUGS, 1998, 9 (09) :825-832
[10]   Ataxia-telangiectasia, an evolving phenotype [J].
Chun, HH ;
Gatti, RA .
DNA REPAIR, 2004, 3 (8-9) :1187-1196